Role of Tranexamic acid in reducing blood loss during Cesarean section.
Phase 4
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2024/05/067500
- Lead Sponsor
- All India Institute of Medical Sciences Bibinagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All antenatal women = 18 years of age with singleton pregnancy planned for elective LSCS at gestation = 34 weeks.
Exclusion Criteria
1. Women undergoing vaginal delivery
2. History of coagulation or thrombotic disorders, 3. Emergency LSCS,
4. Abruption or placenta praevia,
5. Abnormally invasive placenta,
6. Multifetal gestation,
7. Preeclampsia or HELLP syndrome,
8. Eclampsia,
9. Intrauterine fetal demise,
10. Polyhydramnios,
11. History of epilepsy or seizure,
12. Anticoagulant drugs or LMW Heparin,
13. Anemia/cardiac/renal/liver disease,
14. Hypersensitivity to TXA,
15. CS being done under General anesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method